1. Home
  2. COLL vs RDWR Comparison

COLL vs RDWR Comparison

Compare COLL & RDWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • RDWR
  • Stock Information
  • Founded
  • COLL 2002
  • RDWR 1996
  • Country
  • COLL United States
  • RDWR Israel
  • Employees
  • COLL N/A
  • RDWR N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • RDWR EDP Services
  • Sector
  • COLL Health Care
  • RDWR Technology
  • Exchange
  • COLL Nasdaq
  • RDWR Nasdaq
  • Market Cap
  • COLL 910.2M
  • RDWR 889.9M
  • IPO Year
  • COLL 2015
  • RDWR 1999
  • Fundamental
  • Price
  • COLL $26.79
  • RDWR $23.19
  • Analyst Decision
  • COLL Strong Buy
  • RDWR Hold
  • Analyst Count
  • COLL 5
  • RDWR 4
  • Target Price
  • COLL $43.60
  • RDWR $27.00
  • AVG Volume (30 Days)
  • COLL 393.2K
  • RDWR 160.6K
  • Earning Date
  • COLL 05-08-2025
  • RDWR 05-07-2025
  • Dividend Yield
  • COLL N/A
  • RDWR N/A
  • EPS Growth
  • COLL 43.56
  • RDWR N/A
  • EPS
  • COLL 1.86
  • RDWR 0.14
  • Revenue
  • COLL $631,449,000.00
  • RDWR $274,880,000.00
  • Revenue This Year
  • COLL $19.96
  • RDWR $9.54
  • Revenue Next Year
  • COLL $3.93
  • RDWR $7.54
  • P/E Ratio
  • COLL $14.31
  • RDWR $164.79
  • Revenue Growth
  • COLL 11.41
  • RDWR 5.20
  • 52 Week Low
  • COLL $23.23
  • RDWR $16.53
  • 52 Week High
  • COLL $42.29
  • RDWR $25.00
  • Technical
  • Relative Strength Index (RSI)
  • COLL 43.80
  • RDWR 62.91
  • Support Level
  • COLL $25.87
  • RDWR $19.64
  • Resistance Level
  • COLL $27.95
  • RDWR $21.55
  • Average True Range (ATR)
  • COLL 1.50
  • RDWR 1.10
  • MACD
  • COLL 0.05
  • RDWR 0.33
  • Stochastic Oscillator
  • COLL 69.33
  • RDWR 89.41

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About RDWR Radware Ltd.

Radware Ltd provides cyber security and application delivery solutions. The company provides solutions for cloud, on-premises, and software-defined data centers (SDDC). The solutions of the company secure the digital experience by providing infrastructure, application, and network protection and availability services to enterprises globally. The business segments of the company are Radware's Core Business and The Hawks' Business. The company derives maximum revenue from Radware's Core Business. The company generates maximum revenue from the United States.

Share on Social Networks: